Tag: Wavelinq
“EndoAVF 2.0” projects evaluated in CX debate
The advent of endovascular arteriovenous fistula (endoAVF) creation with the development of the Ellipsys (Medtronic) and WavelinQ (BD) systems marks a “major innovation in...
EVA DROP study to assess blood pressure changes and cardiac output...
At this year’s EndoVascular Access (EVA; 24–25 June, Patras, Greece) meeting, the design and intentions of the EVA DROP study—which will seek to evaluate blood...
Vascular access creation: EndoAVF keeps future options open, but is not...
Based on over four years of experience in a single centre, Robert Shahverdyan (Asklepios Klinik Barmbek, Hamburg, Germany) claims that endovascular arteriovenous fistula (endoAVF)...
Largest patient series to date reinforces 4Fr WavelinQ system’s potential in...
A multicentre experience with the 4 French (4Fr) WavelinQ endoAVF system (BD) has found that the device is safe and effective, bolstering existing evidence...
Study indicates lower wound infection and surgical reintervention rates in pAVF...
A single-centre, retrospective, comparative study, which was presented at the July 2021 Journal of Vascular Surgery (JVS) Journal Club (14 July, online), has found...
Cannulation difficulties among biggest hurdles for device-created fistulas
Difficulties in cannulation are currently as pressing as any other challenge facing patients who undergo device-enabled arteriovenous fistula (AVF) creation for dialysis. This was...
The WavelinQ™ EndoAVF System takes an innovative approach in creating endovascular...
NOTE: This advertorial is ONLY available to watch in selected countries and geographies
This advertorial, sponsored by BD, is intended for readers in the...
BD announces enrolment in postmarket studies of the WavelinQ endoAVF system
BD announced today that enrolment has begun and the first patients have been treated in the postmarket surveillance study, CONNECT-AV.
CONNECT-AV is a prospective, single-arm,...